Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Macfarlanes advised Improbable Worlds Limited while DWF acted for Keywords Studios on the deal. Keywords Studios, the international provider of creative and technology-enabled solutions to the...
You must be a Standard 1 Year member to access this content.
Macfarlanes advised PMG on its acquisition of RocketMill. PMG has acquired UK-based RocketMill, a leading independent, full-service digital marketing agency. The combined strengths of PMG and...
You must be a Standard 1 Year member to access this content.
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised CytomX in the transaction. CytomX Therapeutics, Inc. (NASDAQ: CTMX), a leader in the field of conditionally activated oncology therapeutics and Moderna,...
You must be a Standard 1 Year member to access this content.
Sidley represented Distributed Solar Development, LLC on the deal. Distributed Solar Development, LLC (“DSD”), a leader in large-scale, custom solar PV and energy storage solutions, announced a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented CytomX in the transaction. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Orbital Therapeutics on the deal. Orbital Therapeutics, which aims to enhance global health by unleashing the full potential of RNA medicine, announced...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised private pension fund provider Universities Superannuation Scheme. The pension fund acquired the underlying real estate interest of the holiday resort operator’s sites at...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented HilleVax, while Davis Polk advised the joint book-running managers in the IPO. HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and...
You must be a Standard 1 Year member to access this content.
Orrick, Herrington & Sutcliffe advised Twist Bioscience, while Latham & Watkins represented the underwriters in the offering. Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers...
You must be a Standard 1 Year member to access this content.
